Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Sun Pharma announces receipt of European Commission approval for ILUMETRI® by Almirall

Posted On: 2018-09-18 17:26:26

Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associate companies) today announced that Almirall has received the European Commission (EC) approval for ILUMETRI® (tildrakizumab) for the treatment of adults with moderate-to-severe chronic plaque psoriasis who are candidates for systemic therapy. As indicated by Almirall, roll out of ILUMETRI® in Europe will start in the next few weeks. In July 2016, Sun Pharma out-licensed tildrakizumab to Almirall, for the development and commercialization of the product for psoriasis in Europe.

Tildrakizumab is a humanized high-affinity anti-IL-23p19 monoclonal antibody1. Due to its specific mechanism of action, it selectively blocks interleukin-23 (IL-23), an upstream inflammatory mediator cytokine, and acts by modifying the pathogenesis of the disease with limited impact on the rest of the immune system.

Its approval in Europe is based on the positive results from reSURFACE 1 and 2 phase-3 clinical trials3, presented for the first time in October 2016 at the 25th European Academy of Dermatology and Venerology (EADV) Congress in Vienna (Austria). Both pivotal phase-3 clinical trials, which included over 1,800 patients from more than 200 clinical sites worldwide, showed ILUMETRI® has a high level of safety and efficacy.

According to both studies data, an average of 63% of patients achieved 75% of skin clearance (Psoriasis Area Sensitivity Index or PASI 75) by week 12 and an average of 78% at week 28. Moreover, an average of 59% of patients achieved PASI 90 and an average of 30% reached PASI 100 at week 28. Over a year, more than 92% of patients who responded to ILUMETRI® within 28 weeks maintained a PASI 75 response.

Moreover, the results of a pooled analysis through three years2 from resurface 1 and 2 phase-3 trials show the consistent maintenance of efficacy and safety over three years of ILUMETRI® in patients with moderate-to-severe chronic plaque psoriasis who were responders at week 28. According to the data, PASI 75 responses were maintained with continued treatment with ILUMETRI® in 90% of patients up to week 1482 . ILUMETRI® was well-tolerated with very low drug-related serious adverse events and discontinuation rates.

Shares of SUN PHARMACEUTICAL INDUSTRIES LTD. was last trading in BSE at Rs.642.3 as compared to the previous close of Rs. 646.15. The total number of shares traded during the day was 321970 in over 5595 trades.

The stock hit an intraday high of Rs. 655.75 and intraday low of 640. The net turnover during the day was Rs. 209131797.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Manappuram Finance Ltd to acquire 100% in Manappuram Comptech & Consultants Ltd

BEML Ltd board declares interim dividend of Rs. 4.50

Power supply restored at Amit Spinning Industries Ltd's factory

Pierer Industrie and Bajaj in discussions for Bajaj to participate at KTM Industries level

PFC signs agreement to acquire majority stake in REC Limited

Infosys and Roland-Garros Partner for Digital Innovation

DIAL awards the Commercial Development Rights at Aerocity, Delhi to a consortium led by M/s Bharti Realty

Bosch Ltd to form JV with Prettl India Pvt Ltd

Frontline Securities Ltd board to consider buy-back on March 26, 2019

IDFC FIRST Bank Ltd has sold 8.37% stake in ARCIL

Sun TV Network Ltd appoints R Mahesh Kumar as MD

CCL Products India Ltd board to consider interim dividend on March 23, 2019

Greenlam Industries Ltd to increase capacity through brownfield expansion

Smt. Sushmita Dasgupta appointed as Government Director of Indian Oil Corporation Ltd

Promoter group entities of Greaves Cotton Ltd to merge

California Software Company Ltd to consider allotment of OCRPS to Chemoil

Adani Transmission Ltd board approves buy-back of 10,000 NCDs

ABans Enterprises Ltd to acquire Abans Jewels Pvt Ltd

HUDCO updates on medium term note programme

Gopala Polyplast Ltd withdraws QIP

Sayaji Hotels Ltd terminates lease agreement with Barbeque-Nationa

GE T&D India Ltd updates on transformer business

Karnataka Bank opens its 839th Branch at Nadugodu - Kateel

Zensar brings 'Experience Digital Returns' focused solutions to Adobe Summit 2019

Topcoder's Crowdsourced Quality as a Service for On-Demand Testing Enables Faster Speeds, Greater Work Volumes for Customers

Krypton Industries Ltd receives order of Rs. 23.10 crores

CG equipped 'Deutsche Bucht' offshore substation topside sails out

Prima Plastics Ltd's JV declares dividend

Asian Oilfield Services receives LOI from Oilmax for contract of Rs. 210 crores for 10 years

Toyota and Suzuki Agree to Start Consideration toward New Collaboration

HFS Research Ranks HGS in the Top 3 for Voice of the customer in survey of more than 300

REC Ltd approves market borrowing programme for 2019-20

Onida launches smart air conditioners ONYXS and GENIO

Alankit Ltd Board approves interim dividend of Rs. 0.20 for 2018-19

Vodafone Idea Ltd board approves terms of rights issue

SBI Life Insurance Company Ltd fixes Apr 4, 2019 as record date for interim dividend

Newgen Positioned as a Strong Performer in Digital Process Automation for Wide Deployments by Top Independent Research Firm

Colgate Palmolive India Ltd fixes Apr 8, 2019 as record date for second interim dividend

Mahindra & Mahindra Financial Services Ltd allots 5000 NCDs worth Rs. 500 crores

The launch of Wealth Qube - 2020 at Intellect User Meet, Dubai

SHARP India Ltd board meeting to approve appointment of Mr. Naoki Hatayama as MD

Indraprastha Gas Ltd announces cessation of two independent directors

SHARP India Ltd announces resignation of MD

China Telecom Global partners with Tata Communications

HCL and Xerox expand Strategic Partnership to accelerate operational Transformation

Jet Airways India Ltd grounds another 6 aircraft

Vikas WSP Ltd updates on US court litigation

Tata Steel Bsl Ltd allots NCRPS worth Rs. 6500 crore to Tata Steel Ltd

IDBI Bank Ltd approves rupee bond borrowing limit of Rs. 4000 crore

Newgen secures another Patent for its invention - Integrated and Automatic Generation of Carbon Credits







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019